Alpha 1 antitrypsin deficiency due to Pi null: clinical presentation and evidence for molecular heterogeneity
- PMID: 2831367
- PMCID: PMC1015448
- DOI: 10.1136/jmg.25.2.83
Alpha 1 antitrypsin deficiency due to Pi null: clinical presentation and evidence for molecular heterogeneity
Abstract
The proteinase inhibitor null (Pi-) allele is a rare cause of alpha 1 antitrypsin (AAT) deficiency. In three families, all the subjects with AAT deficiency due to PiZ- presented in early childhood with recurrent chest infections and wheezing presumably related to passive smoking. In Pi- the AAT gene is present and there is no evidence for a gene deletion. In one family a restriction fragment length polymorphism (RFLP) detected with the enzyme XbaI segregates with the Pi- allele. In a family where a consanguineous marriage occurred, the XbaI polymorphism segregates with the normal M1 allele rather than Pi-, suggesting that Pi- may have originated from M1. In contrast, a third family and 20 normal unrelated subjects do not show the RFLP.
Similar articles
-
Relationship between a mild alpha 1 proteinase inhibitor deficiency and respiratory symptoms in a family.Ann Clin Biochem. 1995 Nov;32 ( Pt 6):545-9. doi: 10.1177/000456329503200605. Ann Clin Biochem. 1995. PMID: 8579286
-
Genotyping of alpha-antitrypsin in ten Croatian families.Clin Biochem. 2000 Jul;33(5):377-82. doi: 10.1016/s0009-9120(00)00081-3. Clin Biochem. 2000. PMID: 11018689
-
Identification of a new defective SERPINA1 allele (PI*Zla palma) encoding an alpha-1-antitrypsin with altered glycosylation pattern.Respir Med. 2017 Oct;131:114-117. doi: 10.1016/j.rmed.2017.08.015. Epub 2017 Aug 16. Respir Med. 2017. PMID: 28947017
-
Long-term clinical outcomes following treatment with alpha 1-proteinase inhibitor for COPD associated with alpha-1 antitrypsin deficiency: a look at the evidence.Respir Res. 2017 May 30;18(1):105. doi: 10.1186/s12931-017-0574-1. Respir Res. 2017. PMID: 28558837 Free PMC article. Review.
-
Alpha 1-antitrypsin deficiency: memorandum from a WHO meeting.Bull World Health Organ. 1997;75(5):397-415. Bull World Health Organ. 1997. PMID: 9447774 Free PMC article. Review.
Cited by
-
Leveraging Population Genomics for Individualized Correction of the Hallmarks of Alpha-1 Antitrypsin Deficiency.Chronic Obstr Pulm Dis. 2020 Jul;7(3):224-246. doi: 10.15326/jcopdf.7.3.2019.0167. Chronic Obstr Pulm Dis. 2020. PMID: 32726074 Free PMC article. Review.
-
Molecular characterisation of two alpha-1-antitrypsin deficiency variants: proteinase inhibitor (Pi) Null(Newport) (Gly115----Ser) and (Pi) Z Wrexham (Ser-19----Leu).Hum Genet. 1990 Oct;85(5):537-40. doi: 10.1007/BF00194233. Hum Genet. 1990. PMID: 2227940
-
Novel SERPINA1 Alleles Identified through a Large Alpha-1 Antitrypsin Deficiency Screening Program and Review of Known Variants.Chronic Obstr Pulm Dis. 2023 Jan 25;10(1):7-21. doi: 10.15326/jcopdf.2022.0321. Chronic Obstr Pulm Dis. 2023. PMID: 36367950 Free PMC article.
-
Why has it been so difficult to prove the efficacy of alpha-1-antitrypsin replacement therapy? Insights from the study of disease pathogenesis.Drug Des Devel Ther. 2011;5:391-405. doi: 10.2147/DDDT.S14018. Epub 2011 Aug 17. Drug Des Devel Ther. 2011. PMID: 21966212 Free PMC article. Review.
-
Molecular characterisation of three alpha-1-antitrypsin deficiency variants: proteinase inhibitor (Pi) nullcardiff (Asp256----Val); PiMmalton (Phe51----deletion) and PiI (Arg39----Cys).Hum Genet. 1989 Dec;84(1):55-8. doi: 10.1007/BF00210671. Hum Genet. 1989. PMID: 2606478
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous